• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BDNF 通过 AKT 磷酸化抑制神经退行性疾病相关天冬酰胺内肽酶活性。

BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT.

机构信息

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

Department of Pathophysiology, Key Laboratory of Ministry of Education of Neurological Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

JCI Insight. 2018 Aug 23;3(16). doi: 10.1172/jci.insight.99007.

DOI:10.1172/jci.insight.99007
PMID:30135302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6141178/
Abstract

AEP is an age-dependent lysosomal asparaginyl endopeptidase that cleaves numerous substrates including tau and α-synuclein and mediates their pathological roles in neurodegenerative diseases. However, the molecular mechanism regulating this critical protease remains incompletely understood. Here, we show that Akt phosphorylates AEP on residue T322 upon brain-derived neurotrophic factor (BDNF) treatment and triggers its lysosomal translocation and inactivation. When BDNF levels are reduced in neurodegenerative diseases, AEP T322 phosphorylation is attenuated. Consequently, AEP is activated and translocates into the cytoplasm, where it cleaves both tau and α-synuclein. Remarkably, the unphosphorylated T322A mutant increases tau or α-synuclein cleavage by AEP and augments cell death, whereas phosphorylation mimetic T322E mutant represses these effects. Interestingly, viral injection of T322E into Tau P301S mice antagonizes tau N368 cleavage and tau pathologies, rescuing synaptic dysfunction and cognitive deficits. By contrast, viral administration of T322A into young α-SNCA mice elicits α-synuclein N103 cleavage and promotes dopaminergic neuronal loss, facilitating motor defects. Therefore, our findings support the notion that BDNF contributes to the pathogenesis of neurodegenerative diseases by suppressing AEP via Akt phosphorylation.

摘要

AEP 是一种依赖年龄的溶酶体天冬酰胺内肽酶,可切割包括 tau 和 α-synuclein 在内的多种底物,并介导它们在神经退行性疾病中的病理作用。然而,调节这种关键蛋白酶的分子机制仍不完全清楚。在这里,我们表明脑源性神经营养因子 (BDNF) 处理会使 Akt 在 AEP 的 T322 残基上磷酸化,并触发其溶酶体易位和失活。当神经退行性疾病中 BDNF 水平降低时,AEP T322 磷酸化会减弱。因此,AEP 被激活并易位到细胞质中,在细胞质中它会切割 tau 和 α-synuclein。值得注意的是,未磷酸化的 T322A 突变体增加了 AEP 对 tau 或 α-synuclein 的切割,并增强了细胞死亡,而磷酸化模拟 T322E 突变体抑制了这些效应。有趣的是,将 T322E 病毒注入 Tau P301S 小鼠中可拮抗 tau N368 的切割和 tau 病理学,挽救突触功能障碍和认知缺陷。相比之下,将 T322A 病毒注入年轻的 α-SNCA 小鼠中会引发 α-synuclein N103 的切割,并促进多巴胺能神经元丢失,从而促进运动缺陷。因此,我们的发现支持这样一种观点,即 BDNF 通过 Akt 磷酸化抑制 AEP 来促进神经退行性疾病的发病机制。

相似文献

1
BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT.BDNF 通过 AKT 磷酸化抑制神经退行性疾病相关天冬酰胺内肽酶活性。
JCI Insight. 2018 Aug 23;3(16). doi: 10.1172/jci.insight.99007.
2
Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies.Delta 分泌酶切割的 Tau 拮抗 TrkB 神经营养信号,介导阿尔茨海默病病理学。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9094-9102. doi: 10.1073/pnas.1901348116. Epub 2019 Apr 19.
3
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.天冬酰胺内肽酶介导的 tau 裂解介导阿尔茨海默病的神经纤维病理。
Nat Med. 2014 Nov;20(11):1254-62. doi: 10.1038/nm.3700. Epub 2014 Oct 19.
4
Initiation of Parkinson's disease from gut to brain by δ-secretase.δ-分泌酶介导帕金森病从肠道到大脑的发病过程
Cell Res. 2020 Jan;30(1):70-87. doi: 10.1038/s41422-019-0241-9. Epub 2019 Oct 24.
5
Amphiphysin I cleavage by asparagine endopeptidase leads to tau hyperphosphorylation and synaptic dysfunction.天冬酰胺内肽酶导致 amphiphysin I 裂解,从而引起 tau 过度磷酸化和突触功能障碍。
Elife. 2021 May 21;10:e65301. doi: 10.7554/eLife.65301.
6
Mechanism of Tau Hyperphosphorylation Involving Lysosomal Enzyme Asparagine Endopeptidase in a Mouse Model of Brain Ischemia.脑缺血小鼠模型中溶酶体天冬酰胺内肽酶涉及 Tau 过度磷酸化的机制。
J Alzheimers Dis. 2018;63(2):821-833. doi: 10.3233/JAD-170715.
7
α-Synuclein stimulation of monoamine oxidase-B and legumain protease mediates the pathology of Parkinson's disease.α-突触核蛋白刺激单胺氧化酶-B 和凝乳蛋白酶介导帕金森病的病理学。
EMBO J. 2018 Jun 15;37(12). doi: 10.15252/embj.201798878. Epub 2018 May 16.
8
Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease.天冬酰胺内肽酶切割α-突触核蛋白并介导帕金森病的病理活动。
Nat Struct Mol Biol. 2017 Aug;24(8):632-642. doi: 10.1038/nsmb.3433. Epub 2017 Jul 3.
9
Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.SRPK2介导的δ-分泌酶磷酸化增强其酶活性,引发阿尔茨海默病的发病机制。
Mol Cell. 2017 Sep 7;67(5):812-825.e5. doi: 10.1016/j.molcel.2017.07.018. Epub 2017 Aug 17.
10
Asparagine endopeptidase cleaves tau at N167 after uptake into microglia.天冬酰胺内肽酶在被小胶质细胞摄取后在 N167 处切割 tau。
Neurobiol Dis. 2019 Oct;130:104518. doi: 10.1016/j.nbd.2019.104518. Epub 2019 Jun 21.

引用本文的文献

1
BIN1 Interacts with Tau Fragments to Inhibit TrkB Signaling Endosome Recycling in a Mouse Model of Alzheimer's Disease.在阿尔茨海默病小鼠模型中,BIN1与Tau片段相互作用以抑制TrkB信号内体循环。
Neurosci Bull. 2025 Jun 18. doi: 10.1007/s12264-025-01435-y.
2
Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition.针对tau片段的免疫疗法可减轻阿尔茨海默病病理,改善突触功能和认知。
Mol Neurodegener. 2025 May 27;20(1):60. doi: 10.1186/s13024-025-00854-9.
3
SG06, a Chalcone Derivative Targets PI3K/AKT1 Pathway for Neuroprotection and Cognitive Enhancement in an Alzheimer's Disease-Like Zebrafish Model.SG06,一种查尔酮衍生物,在类似阿尔茨海默病的斑马鱼模型中靶向PI3K/AKT1通路以实现神经保护和认知增强。
Mol Neurobiol. 2025 May 10. doi: 10.1007/s12035-025-05023-z.
4
CDO1 phosphorylation is required for IL-6-induced tumor cell proliferation through governing cysteine availability.CDO1磷酸化通过控制半胱氨酸的可用性来促进白细胞介素-6诱导的肿瘤细胞增殖。
Cell Commun Signal. 2025 Apr 23;23(1):194. doi: 10.1186/s12964-025-02189-w.
5
BDNF-TrkB Signaling in Mitochondria: Implications for Neurodegenerative Diseases.线粒体中的脑源性神经营养因子-酪氨酸激酶B信号传导:对神经退行性疾病的影响
Mol Neurobiol. 2025 Feb;62(2):1756-1769. doi: 10.1007/s12035-024-04357-4. Epub 2024 Jul 19.
6
GDF1 ameliorates cognitive impairment induced by hearing loss.GDF1 可改善听力损失引起的认知障碍。
Nat Aging. 2024 Apr;4(4):568-583. doi: 10.1038/s43587-024-00592-5. Epub 2024 Mar 15.
7
Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer's disease in mice.天冬酰胺内肽酶(AEP)抑制剂能有效治疗散发性阿尔茨海默病小鼠模型。
Neuropsychopharmacology. 2024 Feb;49(3):620-630. doi: 10.1038/s41386-023-01774-2. Epub 2023 Nov 29.
8
Mechanisms of the Beneficial Effects of Exercise on Brain-Derived Neurotrophic Factor Expression in Alzheimer's Disease.运动对阿尔茨海默病脑源性神经营养因子表达的有益影响的机制。
Biomolecules. 2023 Oct 26;13(11):1577. doi: 10.3390/biom13111577.
9
Temperature- and chemical-induced neurotoxicity in zebrafish.斑马鱼中温度和化学物质诱导的神经毒性。
Front Physiol. 2023 Oct 3;14:1276941. doi: 10.3389/fphys.2023.1276941. eCollection 2023.
10
Zein-Based Nanoparticles Improve the Therapeutic Efficacy of a TrkB Agonist toward Alzheimer's Disease.基于玉米醇溶蛋白的纳米颗粒提高了一种 TrkB 激动剂治疗阿尔茨海默病的疗效。
ACS Chem Neurosci. 2023 Sep 6;14(17):3249-3264. doi: 10.1021/acschemneuro.3c00401. Epub 2023 Aug 15.

本文引用的文献

1
Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.SRPK2介导的δ-分泌酶磷酸化增强其酶活性,引发阿尔茨海默病的发病机制。
Mol Cell. 2017 Sep 7;67(5):812-825.e5. doi: 10.1016/j.molcel.2017.07.018. Epub 2017 Aug 17.
2
Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis.天冬酰胺内肽酶的阻断抑制癌症转移。
J Med Chem. 2017 Sep 14;60(17):7244-7255. doi: 10.1021/acs.jmedchem.7b00228. Epub 2017 Aug 18.
3
Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease.天冬酰胺内肽酶切割α-突触核蛋白并介导帕金森病的病理活动。
Nat Struct Mol Biol. 2017 Aug;24(8):632-642. doi: 10.1038/nsmb.3433. Epub 2017 Jul 3.
4
Glycosylation is important for legumain localization and processing to active forms but not for cystatin E/M inhibitory functions.糖基化对于天冬酰胺酶的定位以及加工成活性形式很重要,但对于半胱氨酸蛋白酶抑制剂E/M的抑制功能则不重要。
Biochimie. 2017 Aug;139:27-37. doi: 10.1016/j.biochi.2017.05.009. Epub 2017 May 17.
5
Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.抑制 δ-分泌酶可改善阿尔茨海默病小鼠模型的认知功能。
Nat Commun. 2017 Mar 27;8:14740. doi: 10.1038/ncomms14740.
6
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease.δ-分泌酶切割淀粉样前体蛋白并调节阿尔茨海默病的发病机制。
Nat Commun. 2015 Nov 9;6:8762. doi: 10.1038/ncomms9762.
7
TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.在5XFAD小鼠中,TrkB减少会加剧阿尔茨海默病样信号异常和记忆缺陷,而不影响β-淀粉样变性。
Transl Psychiatry. 2015 May 5;5(5):e562. doi: 10.1038/tp.2015.55.
8
Quantitative protein analysis by mass spectrometry.基于质谱法的蛋白质定量分析。
Methods Mol Biol. 2015;1278:281-305. doi: 10.1007/978-1-4939-2425-7_17.
9
Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.半胱氨酸组织蛋白酶和天冬酰胺内肽酶介导的蛋白水解作用——最新进展与细胞生物学挑战
Protoplasma. 2015 May;252(3):755-74. doi: 10.1007/s00709-014-0730-0. Epub 2014 Nov 16.
10
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.天冬酰胺内肽酶介导的 tau 裂解介导阿尔茨海默病的神经纤维病理。
Nat Med. 2014 Nov;20(11):1254-62. doi: 10.1038/nm.3700. Epub 2014 Oct 19.